Cargando…
Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes
The small molecule cyclotriazadisulfonamide (CADA) down-modulates the human CD4 receptor, an important factor in T cell activation. Here, we addressed the immunosuppressive potential of CADA using different activation models. CADA inhibited lymphocyte proliferation with low cellular toxicity in a mi...
Autores principales: | Claeys, Elisa, Pauwels, Eva, Humblet-Baron, Stephanie, Provinciael, Becky, Schols, Dominique, Waer, Mark, Sprangers, Ben, Vermeire, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097030/ https://www.ncbi.nlm.nih.gov/pubmed/33968048 http://dx.doi.org/10.3389/fimmu.2021.650731 |
Ejemplares similares
-
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide
por: Pauwels, Eva, et al.
Publicado: (2021) -
Reduced DNAJC3 Expression Affects Protein Translocation across the ER Membrane and Attenuates the Down-Modulating Effect of the Translocation Inhibitor Cyclotriazadisulfonamide
por: Pauwels, Eva, et al.
Publicado: (2022) -
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants
por: Vanhulle, Emiel, et al.
Publicado: (2023) -
Intracellular flow cytometry complements RT-qPCR detection of circulating SARS-CoV-2 variants of concern
por: Vanhulle, Emiel, et al.
Publicado: (2022) -
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern
por: Vanhulle, Emiel, et al.
Publicado: (2022)